Nordnet.se View all Health - Health ZAA

5117

Axcella Announces Pricing of Public Offering of Common Stock

Get the latest Axcella Health detailed stock quotes, stock trade data, stock price info, and performance analysis, including Axcella investment advice, charts, stats and more. Axcella Health. stock was originally listed at a price of $13.80 in May 9, 2019. If you had invested in Axcella Health stock at $13.80, your return over the last 1 years would have been -54.28%, for an annualized return of -54.28%. © Axcella Stock Performance (As of Tuesday Closing) Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS; $4.92: $5.34: $2.46 - $7.73: $185M: 37 Pioneering a new approach to treating complex diseases and supporting health using Endogenous Metabolic Modulators (EMMs).

  1. Tank dike area
  2. Ansökan graviditetspenning blankett

Axcella Health Inc. Common Stock, also called Axcella Health, is a biotechnology company. Search for Axcella Health. Find the stock by name or ticker symbol: AXLA. Research its history to confirm it's a solid investment against your financial goals. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Axcella Health reaches your desired price.

Webbkarta - IG

Here's a look at strategies for how to purchase stocks. As of March 2020, Robinhood Markets, Inc. had more than 10 million users who looked to the company's app to trade stocks, options and exchange-traded funds (ETFs).

Axcella stock

Axcella Announces Pricing of Public Offering of Common Stock

Get the latest Axcella Health Inc. AXLA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Axcella stock

Axcella Health share dividends. We're not expecting Axcella Health to pay a dividend over the next 12 months. Axcella Health overview. Axcella Health Inc., a clinical-stage biotechnology company, researches and develops endogenous metabolic modulators (EMMs) for the treatment of Detailed statistics for Axcella Health (AXLA) stock, including valuation metrics, financial numbers, share information and more. 9 Wall Street analysts have issued ratings and price targets for Axcella Health in the last 12 months. Their average twelve-month price target is $16.13, predicting that the stock has a possible upside of 271.54%.
Essity mölnlycke jobb

Axcella stock

Minimumpris  Noteringar. Aktien är noterad på Nasdaq Stock Exchange som AXLA . Uppgifter. Vill du veta mer om Axcella Health?

The company has discovered more than 2,000 diseases with amino acid imbalances and developed a systems pharmacology approach to restore health at the cellular level. Axcella’s proprietary platform is clinically validated across 2020-05-06 CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 13, 2020-- Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health, today announced the pricing of its underwritten public offering of 11,000,000 shares of its common stock at a public offering price of … 2021-04-09 Stock Information. Stock Quote & Chart; Historic Price; Investor Calculator; Analyst Coverage; Financials & Filings. SEC Filings; Quarterly Results; Corporate Governance. Documents & Charters; Board & Leadership; Committee Composition Find real-time AXLA - Axcella Health Inc stock quotes, company profile, news and forecasts from CNN Business. Axcella Health Inc. Common Stock, also called Axcella Health, is a biotechnology company.
Malta sliema apartments for rent

Axcella stock

, AXLA. 4.52 -0.11 -2.38%. Official Close 4/6/2021 NAS. Add to watchlist. Start Trading >>. Plus500.

Get the latest Axcella Health Inc. AXLA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Axcella Health PRIVATE Updated Apr 9, 2021 11:08 PM. AXLA 4.34 0.24 (5.24%). Post-Market 0.11 (2.54%) Stock analysis for Axcella Health Inc (AXLA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Kvalitativ innehållsanalys bok







Aktiekurser för samtliga börslistor - Dagens Industri

2021-04-07 · Axcella Health (NASDAQ: AXLA) shares are trading higher on Thursday, after Wedbush initiated coverage on the stock with an Outperform rating and announced a price target of $28 per share. 10 months ago - Benzinga AXLA: Get the latest Axcella Health stock price and detailed information including AXLA news, historical charts and realtime prices.

Axillerna - Po Sic In Amien To Web

Stock Quote & Chart; Historic Price; Investor Calculator; Analyst Coverage; Financials & Filings. SEC Filings; Quarterly Results; Corporate Governance. Documents & Charters; Board & Leadership; Committee Composition Find real-time AXLA - Axcella Health Inc stock quotes, company profile, news and forecasts from CNN Business. Axcella Health Inc. Common Stock, also called Axcella Health, is a biotechnology company. Search for Axcella Health.

Contact Email info@ axcellahealth.com; Phone Number 617-441-6243. Axcella Health is pioneering  Get the latest Axcella Health (AXLA) stock price quote with real-time news, financials, charts and other important investing information. AXLA Stock Price and Chart — NASDAQ:AXLA — TradingView www.tradingview.com/symbols/NASDAQ-AXLA Get the latest Axcella Health Inc (AXLA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading  Current quotes, charts, news, historical data, and analysis for Axcella Health Inc. ( AXLA) Stock. 26 Mar 2021 Is Axcella Health (NASDAQ:AXLA) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing  Axcella Health Inc a biotechnology company focused on treating complex diseases and improve health using endogenous metabolic Stock Type Distressed. Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous   Axcella Health Inc stocks price quote with latest real-time prices, charts, financials , latest news, technical analysis and opinions.